Direct acting sympathomimetics – Oxymetazoline MCQs With Answer
Direct acting sympathomimetics such as oxymetazoline are widely used α-adrenergic agonists for topical nasal decongestion and ocular vasoconstriction. This SEO-focused introduction for B. Pharm students highlights mechanism of action, receptor selectivity (α1/α2), pharmacodynamics, pharmacokinetics, therapeutic uses, adverse effects including rhinitis medicamentosa, tachyphylaxis, interactions (MAO inhibitors, antihypertensives), dosing, formulations and safe dispensing. Detailed items include pharmacodynamics, structure-activity relationships, systemic absorption risks, and monitoring parameters for safe clinical use. These practice MCQs emphasize clinical reasoning, drug classification (direct vs indirect sympathomimetics) and rational pharmaceutical care. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which receptors are primarily activated by oxymetazoline?
- β1 and β2 adrenergic receptors
- α1 and α2 adrenergic receptors
- Dopamine D1 receptors
- Muscarinic M3 receptors
Correct Answer: α1 and α2 adrenergic receptors
Q2. The primary therapeutic effect of topical oxymetazoline in the nose is due to:
- Inhibition of acetylcholinesterase
- Blockade of histamine H1 receptors
- Vasoconstriction of nasal mucosal arterioles
- Stimulation of mucus secretion
Correct Answer: Vasoconstriction of nasal mucosal arterioles
Q3. Oxymetazoline is classified as a:
- Indirect sympathomimetic
- Nonselective beta blocker
- Direct acting sympathomimetic
- M cholinergic agonist
Correct Answer: Direct acting sympathomimetic
Q4. A common OTC nasal formulation concentration of oxymetazoline for adults is:
- 0.001%
- 0.025%
- 0.05%
- 1.0%
Correct Answer: 0.05%
Q5. Which adverse effect is most specifically associated with prolonged topical oxymetazoline use?
- Renal failure
- Rebound nasal congestion (rhinitis medicamentosa)
- Hepatotoxicity
- Severe hypoglycemia
Correct Answer: Rebound nasal congestion (rhinitis medicamentosa)
Q6. The recommended maximum duration of continuous intranasal oxymetazoline use to avoid rebound congestion is about:
- 1 day
- 3 days
- 14 days
- 30 days
Correct Answer: 3 days
Q7. Oxymetazoline’s long duration of action compared with phenylephrine is primarily because of:
- Higher lipophilicity and prolonged receptor binding
- Extensive first-pass hepatic metabolism
- Strong beta receptor affinity
- Action as a prodrug
Correct Answer: Higher lipophilicity and prolonged receptor binding
Q8. Which of the following is a clinically important drug interaction with oxymetazoline?
- Concurrent MAO inhibitor use increasing hypertensive risk
- Concurrent metformin causing hypoglycemia
- Concurrent antacids reducing effect
- Concurrent vitamin C increasing clearance
Correct Answer: Concurrent MAO inhibitor use increasing hypertensive risk
Q9. The mechanism underlying tachyphylaxis to topical oxymetazoline is mainly:
- Increased metabolic degradation by CYP3A4
- Receptor down-regulation and desensitization
- Accumulation of drug in fat tissue
- Antibody formation against the drug
Correct Answer: Receptor down-regulation and desensitization
Q10. Which excipient commonly found in nasal sprays can contribute to mucosal irritation?
- Glycerin
- Benzalkonium chloride
- Sodium chloride
- Gluconic acid
Correct Answer: Benzalkonium chloride
Q11. Which systemic effect can occur if large amounts of topical oxymetazoline are absorbed?
- Hypotension with reflex tachycardia
- Hypertension with possible bradycardia
- Profound hypokalemia
- Fatal hypoglycemia
Correct Answer: Hypertension with possible bradycardia
Q12. Oxymetazoline’s onset of action when applied intranasally is typically:
- Within seconds to a few minutes
- After 24 hours
- After 3–4 days
- Only after liver activation
Correct Answer: Within seconds to a few minutes
Q13. A key counseling point for patients using oxymetazoline nasal spray is:
- Use continuously for at least 2 weeks for best effect
- Limit use to the shortest duration possible, ideally ≤3 days
- Avoid rinsing the nostrils after each use
- Store at high temperatures
Correct Answer: Limit use to the shortest duration possible, ideally ≤3 days
Q14. Oxymetazoline’s effect on nasal blood flow is best described as:
- Increase in mucosal blood flow
- Decrease in mucosal blood flow via vasoconstriction
- No change in blood flow but increased secretions
- Anticoagulant effect
Correct Answer: Decrease in mucosal blood flow via vasoconstriction
Q15. Which patient condition requires caution or avoidance of oxymetazoline?
- Stable hypothyroidism
- Severe uncontrolled hypertension or ischemic heart disease
- Iron deficiency anemia
- Mild seasonal allergic rhinitis without comorbidity
Correct Answer: Severe uncontrolled hypertension or ischemic heart disease
Q16. In ocular formulations, oxymetazoline is primarily used to:
- Lower intraocular pressure
- Reduce conjunctival hyperemia by vasoconstriction
- Induce miosis
- Act as an antibiotic
Correct Answer: Reduce conjunctival hyperemia by vasoconstriction
Q17. Which statement best differentiates direct from indirect sympathomimetics?
- Direct agents release stored catecholamines only
- Indirect agents directly stimulate adrenergic receptors
- Direct agents bind and activate adrenergic receptors; indirect agents increase endogenous catecholamine release or block reuptake
- There is no pharmacological difference
Correct Answer: Direct agents bind and activate adrenergic receptors; indirect agents increase endogenous catecholamine release or block reuptake
Q18. Which of the following best explains rhinitis medicamentosa from oxymetazoline?
- Allergic immune response to the drug molecule
- Chronic nasal mucosal edema due to rebound vasodilation after prolonged vasoconstriction
- Permanent destruction of nasal glands within hours
- Bacterial overgrowth caused directly by the drug
Correct Answer: Chronic nasal mucosal edema due to rebound vasodilation after prolonged vasoconstriction
Q19. For pediatric patients, formulations of oxymetazoline with lower concentration are available because:
- Children metabolize it faster so need lower concentration
- To reduce systemic absorption and adverse effects in children
- To improve taste
- Because children require higher potency
Correct Answer: To reduce systemic absorption and adverse effects in children
Q20. Which laboratory monitoring is routinely required for short-term topical oxymetazoline use?
- Frequent liver function tests
- No routine laboratory monitoring for short-term topical use
- Daily serum potassium
- Weekly coagulation profile
Correct Answer: No routine laboratory monitoring for short-term topical use
Q21. Which adverse ocular effect is a potential concern with sympathomimetics in susceptible patients?
- Angle-closure glaucoma precipitated by pupillary changes
- Marked corneal regeneration
- Improved lens transparency
- Decreased tear production causing immediate relief
Correct Answer: Angle-closure glaucoma precipitated by pupillary changes
Q22. Which physicochemical property of oxymetazoline contributes to limited systemic absorption when applied topically?
- High water solubility only
- Moderate lipophilicity and topical formulation designed for local effect
- Large peptide structure preventing absorption
- Being an ionic metal complex
Correct Answer: Moderate lipophilicity and topical formulation designed for local effect
Q23. When counseling about dosing frequency, oxymetazoline nasal spray is typically recommended every:
- 1–2 hours
- 8–10 hours or as indicated, up to twice daily for many products
- Every 48 hours
- Once every 7 days
Correct Answer: 8–10 hours or as indicated, up to twice daily for many products
Q24. Which structural-activity relationship factor often increases α-adrenergic receptor activity in sympathomimetics?
- Bulky substitutions on the amine nitrogen that favor β activity only
- Presence of a phenyl ring with appropriate substitutions and allylic groups favoring α activity
- Peptide bonds at the terminus
- Attachment to a sugar moiety
Correct Answer: Presence of a phenyl ring with appropriate substitutions and allylic groups favoring α activity
Q25. In case of acute accidental ingestion of concentrated oxymetazoline by a child, the immediate pharmacist action should include:
- Recommending home remedies and wait 48 hours
- Advise immediate medical evaluation and contact poison control
- Administer activated charcoal at home without medical advice
- Give oral antihistamine and observe
Correct Answer: Advise immediate medical evaluation and contact poison control
Q26. Oxymetazoline differs from epinephrine because oxymetazoline:
- Is an indirect sympathomimetic
- Has greater selectivity for α receptors and longer topical duration
- Has stronger β1 cardiac stimulation
- Is a muscarinic antagonist
Correct Answer: Has greater selectivity for α receptors and longer topical duration
Q27. Which physiological response can result from intense α1 stimulation by oxymetazoline systemically?
- Bronchodilation primarily
- Peripheral vasoconstriction leading to increased systemic vascular resistance
- Marked insulin release
- Diuresis via ADH inhibition
Correct Answer: Peripheral vasoconstriction leading to increased systemic vascular resistance
Q28. In pharmacology, the term ‘rhinitis medicamentosa’ specifically refers to:
- Allergic rhinitis exacerbated by drugs
- Drug-induced nasal congestion and rebound worsening after topical decongestant overuse
- Infectious rhinitis due to medication contamination
- Chronic fungal infection of the nasal mucosa
Correct Answer: Drug-induced nasal congestion and rebound worsening after topical decongestant overuse
Q29. Which of the following is an appropriate label advice for oxymetazoline nasal spray?
- “Use continuously for children under age 2 for relief”
- “Do not exceed recommended dose; limit use to avoid rebound congestion”
- “Safe to use with MAO inhibitors”
- “No drug interactions expected”
Correct Answer: “Do not exceed recommended dose; limit use to avoid rebound congestion”
Q30. Which pharmacokinetic process is least relevant to topical oxymetazoline’s local effect?
- Systemic absorption leading to first-pass hepatic metabolism
- Local receptor binding at the mucosa
- Retention in the epithelial surface
- Limited systemic distribution from topical dose
Correct Answer: Systemic absorption leading to first-pass hepatic metabolism
Q31. Oxymetazoline’s vasoconstrictive effect is most beneficial in which of the following ENT situations?
- Acute epistaxis control and temporary nasal decongestion
- Treatment of sinus bacterial infection
- Long-term management of chronic rhinosinusitis without addressing cause
- Permanent shrinkage of nasal polyps
Correct Answer: Acute epistaxis control and temporary nasal decongestion
Q32. Which characteristic distinguishes oxymetazoline from systemic sympathomimetics in safety profile?
- Higher risk of systemic side effects with topical use than systemic administration
- Lower systemic exposure and hence generally fewer systemic effects when used topically at recommended doses
- No risk of tachyphylaxis
- Causes significant sedation
Correct Answer: Lower systemic exposure and hence generally fewer systemic effects when used topically at recommended doses
Q33. For community pharmacists, an important supply consideration for oxymetazoline nasal sprays is:
- Always dispense 30-day continuous supply for chronic rhinitis
- Provide clear counseling on short-term use and refer if prolonged symptoms persist
- Recommend combination with systemic vasoconstrictors routinely
- Advise patients to increase dose if effect diminishes
Correct Answer: Provide clear counseling on short-term use and refer if prolonged symptoms persist
Q34. Which is a potential cardiovascular contraindication to using oxymetazoline without medical advice?
- Mild seasonal allergies
- Recent myocardial infarction or uncontrolled hypertension
- Stable osteoarthritis
- Vitamin D deficiency
Correct Answer: Recent myocardial infarction or uncontrolled hypertension
Q35. Which statement about formulation choice is true for oxymetazoline products?
- All oxymetazoline preparations have identical pharmacokinetics regardless of vehicle
- Preservative-free formulations may be preferred for frequent users to reduce irritation
- Only oral tablets exist for oxymetazoline
- Higher concentration always equals fewer side effects
Correct Answer: Preservative-free formulations may be preferred for frequent users to reduce irritation
Q36. Which descriptor best fits oxymetazoline’s action at the molecular level?
- Competitive antagonist at α-adrenergic receptors
- Full agonist at α-adrenergic receptors producing vasoconstriction
- Inhibitor of adrenergic receptor synthesis
- Allosteric modulator of muscarinic receptors
Correct Answer: Full agonist at α-adrenergic receptors producing vasoconstriction
Q37. When considering pharmacovigilance, which adverse event should be reported for oxymetazoline misuse?
- Mild temporary relief after single use
- Persistent rebound congestion after prolonged use
- No improvement in mild cold symptoms
- Transient taste alteration
Correct Answer: Persistent rebound congestion after prolonged use
Q38. Which symptom could indicate systemic overdose of oxymetazoline?
- Lightheadedness, high blood pressure and severe headache
- Mild sneezing only
- Local nasal dryness only
- Immediate relief without adverse effects
Correct Answer: Lightheadedness, high blood pressure and severe headache
Q39. A pharmacology exam question: oxymetazoline’s primary effect on nasal vasculature is mediated through which intracellular mechanism?
- cAMP increase in vascular smooth muscle via β receptors
- IP3-mediated Ca2+ release and smooth muscle contraction via α1 receptors
- Opening of potassium channels causing hyperpolarization
- Activation of nitric oxide synthase causing vasodilation
Correct Answer: IP3-mediated Ca2+ release and smooth muscle contraction via α1 receptors
Q40. Which counseling note is appropriate for elderly patients using oxymetazoline nasal sprays?
- They have no increased susceptibility to systemic effects
- Use caution due to potential increased cardiovascular sensitivity and interactions
- They should double the dose for better effect
- They can safely use it long-term without follow-up
Correct Answer: Use caution due to potential increased cardiovascular sensitivity and interactions
Q41. Which of the following best explains how oxymetazoline can reduce nasal bleeding (epistaxis)?
- By promoting clotting factor production locally
- By vasoconstriction reducing blood flow to nasal mucosa
- By dissolving clots to facilitate healing
- By acting as an antiseptic
Correct Answer: By vasoconstriction reducing blood flow to nasal mucosa
Q42. Which pharmacological property contributes to oxymetazoline’s low incidence of tachycardia when used topically?
- Strong β1 stimulation limiting reflex changes
- Predominant α activity causing vasoconstriction without strong direct cardiac β stimulation at topical doses
- Direct blockade of sympathetic ganglia
- Antagonism at cardiac muscarinic receptors
Correct Answer: Predominant α activity causing vasoconstriction without strong direct cardiac β stimulation at topical doses
Q43. Which is a correct statement about systemic absorption of topical oxymetazoline?
- It is completely prevented by nasal mucosa
- Some systemic absorption can occur, particularly with overuse or damaged mucosa
- Systemic absorption always causes severe hepatotoxicity
- Systemic absorption is beneficial to treat systemic hypotension
Correct Answer: Some systemic absorption can occur, particularly with overuse or damaged mucosa
Q44. Which is an appropriate exam-style question regarding oxymetazoline metabolism?
- Oxymetazoline is an active peptide degraded by gut proteases
- Topical oxymetazoline undergoes some hepatic metabolism if systemically absorbed
- It is excreted entirely unchanged in the feces after intranasal use
- Metabolism is clinically irrelevant in all cases
Correct Answer: Topical oxymetazoline undergoes some hepatic metabolism if systemically absorbed
Q45. Which precaution is most relevant when recommending oxymetazoline to a patient on antihypertensive therapy?
- There are no precautions needed
- Advise caution and consult physician because oxymetazoline can reduce antihypertensive efficacy
- Recommend doubling the antihypertensive dose
- Stop all antihypertensives prior to oxymetazoline use
Correct Answer: Advise caution and consult physician because oxymetazoline can reduce antihypertensive efficacy
Q46. In teaching about receptor selectivity, which phrase correctly describes oxymetazoline?
- Highly selective β2 agonist
- Mixed α1/α2 agonist with predominant α-adrenergic activity
- Muscarinic receptor antagonist
- Pure dopamine agonist
Correct Answer: Mixed α1/α2 agonist with predominant α-adrenergic activity
Q47. Which clinical scenario requires immediate referral rather than self-care with oxymetazoline?
- Mild nasal congestion of a common cold for 1 day
- Severe unilateral nasal bleeding or trauma
- Intermittent sneezing without congestion
- Temporary nasal dryness
Correct Answer: Severe unilateral nasal bleeding or trauma
Q48. Which statement about rebound vasodilation after oxymetazoline is accurate?
- Rebound phenomenon is rare and does not depend on duration of use
- Rebound vasodilation is more likely after prolonged use and causes worsened congestion when drug is stopped
- Rebound only occurs with oral administration
- Rebound vasodilation is prevented by concurrent antihistamines
Correct Answer: Rebound vasodilation is more likely after prolonged use and causes worsened congestion when drug is stopped
Q49. Which statement is true about oxymetazoline and pregnancy counseling?
- Topical use should always be encouraged without assessment
- Use should be evaluated by a healthcare provider weighing benefits and risks
- Oxymetazoline is a proven teratogen and absolutely contraindicated
- It is always safe and requires no discussion
Correct Answer: Use should be evaluated by a healthcare provider weighing benefits and risks
Q50. For exam preparation, which study approach best helps understand oxymetazoline pharmacology?
- Memorizing brand names only
- Integrating mechanism of action, receptor pharmacology, clinical uses, dosing limits and adverse effect management
- Focusing solely on manufacturing processes
- Studying only unrelated drug classes
Correct Answer: Integrating mechanism of action, receptor pharmacology, clinical uses, dosing limits and adverse effect management

